BT8009-230 A Phase 2/3 study of BT8009 as monotherapy and in combination in participants with locally advanced or metastatic urothelial cancer
- Phase II, III
- Trial Category: Genitourinary
Contact(s)
Mary Beth Wilwerding, RN Admin@NEcancertrials.com
Location(s)
Available at Nebraska Cancer Specialists, Omaha and Grand Island, NE locations
Interested in More Information?
Please fill out the form below. Someone will get back to you as soon as possible.
"*" indicates required fields